Two senior appointments for MJL
November 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mjl, nicky oates, nina buckley
UK healthcare agency MJL has made two appointments in Nina Buckley as managing director and Nicky Oates as a senior …
Connect with SHL through our newest Podcast Series
November 7, 2014Sales and Marketing auto injector podcast, auto injector testing, shl podcasts
To help customers better understand SHL products and services, a suite of communication tools including articles, white papers, case studies, …
App could crack fake antimalarial drugs market
November 6, 2014Medical Communications, Sales and Marketing Apple, antimalarial, app, colourassist, malaria, talanta
A cheap iPhone app developed last year has demonstrated high-level effectiveness towards identifying bogus antimalarial treatments. A recent study published …
Lundbeck sales slide as generic competition bites
November 6, 2014Sales and Marketing Ebixa, Lundbeck, Q3, Xenazine, generic, onfi, sabril
Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …
Allergan and Valeant trade blows as shareholder meeting looms
November 6, 2014Sales and Marketing Actavis, Allergan, Forest, Valeant, merger, warner
Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …
Consumers want more from wearables market
November 6, 2014Medical Communications, Sales and Marketing Apple, Microsoft, Samsung, mhealth, pwC, watch, werables
The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …
Roche unveils plans for first Asian diagnostics plant
November 6, 2014Medical Communications, Sales and Marketing Asia-Pacific, China, Roche, asia pacific, asian, manufacturing
Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …
ROCK medical communications appoints MD
November 6, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, ROCK, terence bradley
ROCK medical communications has appointed Terence Bradley to be its managing director. Most recently Bradley was the founding director of …
Former Vodaphone head to lead ABPI comms
November 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aileen Thompson, meadon, vodaphone
The ABPI has appointed a new director of communications in Aileen Thompson, a former Vodaphone head who replaces Catherine Meadon in …
Wales Assembly facing questions over cancer
November 5, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology
The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
Retrospective study backs Iressa use in oesophageal cancer
November 5, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology
A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …
LabCorp buys Covance for $6.1 billion
November 5, 2014Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical
US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …
Horizon Discovery names executive director
November 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Horizon Discovery, david smoller
Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …
AstraZeneca buys biotech Definiens
November 4, 2014Research and Development, Sales and Marketing AstraZeneca, Janssen, MedImmune, Pharmacyclics, binnig, definiens
AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …
Astellas teams up with Proteostasis against protein defects
November 4, 2014Research and Development, Sales and Marketing Astellas, Biogen IDEC, Protein, Proteostasis, upr
Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …
Sir Michael Rawlins appointed chair of MHRA
November 4, 2014Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins
The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …
NICE backs GSK’s leukaemia drug Arzerra following price cut
November 4, 2014Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia
NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …
EMA review for Biogen Idec’s haemophilia A therapy
November 4, 2014Sales and Marketing Biogen, elocta, eloctate, haemophilia a, idec, sobi
The EMA is set to review Biogen Idec and Sobi’s haemophilia A therapy Elocta after validating the drug’s marketing authorisation …
Alnylam poaches VP from Bristol-Myers Squibb
November 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alnylam, pushkal garg
US-based RNAi therapeutics firm Alnylam Pharmaceuticals has appointed Dr Pushkal Garg to the position of senior vice president of its …
AstraZeneca completes respiratory deal with Almirall
November 3, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory
AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
